Regulation of the pleiotropic effects of tissue-resident mast cells.


Journal

The Journal of allergy and clinical immunology
ISSN: 1097-6825
Titre abrégé: J Allergy Clin Immunol
Pays: United States
ID NLM: 1275002

Informations de publication

Date de publication:
10 2019
Historique:
received: 13 04 2018
revised: 29 01 2019
accepted: 01 02 2019
pubmed: 18 2 2019
medline: 11 6 2020
entrez: 18 2 2019
Statut: ppublish

Résumé

Mast cells (MCs), which are best known for their detrimental role in patients with allergic diseases, act in a diverse array of physiologic and pathologic functions made possible by the plurality of MC types. Their various developmental avenues and distinct sensitivity to (micro-) environmental conditions convey extensive heterogeneity, resulting in diverse functions. We briefly summarize this heterogeneity, elaborate on molecular determinants that allow MCs to communicate with their environment to fulfill their tasks, discuss the protease repertoire stored in secretory lysosomes, and consider different aspects of MC signaling. Furthermore, we describe key MC governance mechanisms (ie, the high-affinity receptor for IgE [FcεRI]), the stem cell factor receptor KIT, the IL-4 system, and both Ca

Identifiants

pubmed: 30772496
pii: S0091-6749(19)30207-6
doi: 10.1016/j.jaci.2019.02.004
pii:
doi:

Substances chimiques

IL4 protein, human 0
Receptors, IgE 0
Interleukin-4 207137-56-2
KIT protein, human EC 2.7.10.1
Proto-Oncogene Proteins c-kit EC 2.7.10.1
Calcium SY7Q814VUP

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

S31-S45

Informations de copyright

Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.

Auteurs

Michael Huber (M)

Institute of Biochemistry and Molecular Immunology, Medical Faculty, RWTH Aachen University, Aachen, Germany. Electronic address: mhuber@ukaachen.de.

Andrew C B Cato (ACB)

Karlsruhe Institute of Technology, Institute of Toxicology and Genetics, Eggenstein-Leopoldshafen, Germany.

George K Ainooson (GK)

Karlsruhe Institute of Technology, Institute of Toxicology and Genetics, Eggenstein-Leopoldshafen, Germany.

Marc Freichel (M)

Institute of Pharmacology, Heidelberg University, Medical Faculty, Heidelberg, Germany.

Volodymyr Tsvilovskyy (V)

Institute of Pharmacology, Heidelberg University, Medical Faculty, Heidelberg, Germany.

Rolf Jessberger (R)

Institute for Physiological Chemistry, Medical Faculty Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.

Eva Riedlinger (E)

Institute of Laboratory Medicine, University Hospital, LMU Munich, Munich, Germany.

Christian P Sommerhoff (CP)

Institute of Laboratory Medicine, University Hospital, LMU Munich, Munich, Germany.

Stephan C Bischoff (SC)

Institute of Nutritional Medicine, University of Hohenheim, Stuttgart, Germany. Electronic address: bischoff.stephan@uni-hohenheim.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH